Heidari Nima, Slevin Mark, Zeinolabediny Yasmin, Meloni Davide, Olgiati Stefano, Wilson Adrian, Noorani Ali, Azamfirei Leonard
The Regenerative Clinic, 18-22 Queen Anne Street, London W1G 8HU, UK.
Next AI, London EC3V 1LP, UK.
J Clin Med. 2022 Feb 17;11(4):1056. doi: 10.3390/jcm11041056.
Hip osteoarthritis (OA) is a major contributor to reduced quality of life and concomitant disability associated with lost working life months. Intra-articular injection of various biological materials has shown promise in alleviating symptoms and potentially slowing down the degenerative process. Here, we compared the effects of treatment of a cohort of 147 patients suffering from grade 1-4 hip OA; with either micro-fragmented adipose tissue (MFAT), or a combination of MFAT with platelet-rich plasma (PRP). We found significant improvements in both the visual analogue score for pain (VAS) and Oxford hip score (OHS) that were similar for both treatments with over 60% having an improvement in the VAS score of 20 points or more. These results suggest a positive role for intra-articular injection of MFAT + PRP as a treatment for hip osteoarthritis which may be important particularly in low body mass index (BMI) patients where the difficulty in obtaining sufficient MFAT for treatment could be offset by using this combination of biologicals.
髋关节骨关节炎(OA)是导致生活质量下降以及与工作寿命月数减少相关的残疾的主要原因。关节内注射各种生物材料已显示出缓解症状并可能减缓退变过程的前景。在此,我们比较了147例1-4级髋关节OA患者接受微碎片化脂肪组织(MFAT)治疗,或MFAT与富血小板血浆(PRP)联合治疗的效果。我们发现,两种治疗方法在疼痛视觉模拟评分(VAS)和牛津髋关节评分(OHS)方面均有显著改善,且两种治疗方法相似,超过60%的患者VAS评分改善20分或更多。这些结果表明,关节内注射MFAT + PRP作为髋关节骨关节炎的一种治疗方法具有积极作用,这可能尤其对低体重指数(BMI)患者很重要,因为对于这类患者,使用这种生物材料组合可以弥补获取足够MFAT进行治疗的困难。